[1] Cho HR,Choi JW,Kim HC,et al.Sprague-Dawley rats bearing McA-RH7777 cells for study of hepatoma and transarterial chemoembolization. Anticancer Res,2013,33(1):223-230. [2] Wang GZ,Fang ZT,Zhang W,et al.Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma. Oncol Rep,2014,1(1):95-102. [3] Wang Y,Zheng C,Liang B,et al.Hepatocellular necrosis, apoptosis,and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model. J Vasc Interv Radiol,2011,22(11):1606-1612. [4] 杨晋辉,唐映梅.各种介入治疗肝癌方法临床评价. 实用肝脏病杂志,2015,18(3):230-232. [5] Trübenbach J,Pereira PL,Graepler F,et al.Animal experiment studies on the effectiveness of permanent occlusion of the hepatic artery in transarterial chemoembolization. Rofo,2000,172(3):274-277. [6] Lencioni R,Llovet JM.Modified RECIST(mRECIST)assessment for hepatocellular carcinoma.Semin Liver Dis,2010,30(1):52-60. [7] Hong K,Kobeiter H,Georgiades CS,et al.Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer. J Vasc Interv Radiol,2005,16(12):1711-1717. |